10X Genomics Chromium Controller system/reagent kit
The National Cancer Institute (NCI), Cancer Center Research (CCR), Surgery Branch plans to procure on a sole source basis the brand name 10X Genomics Comium Controller system/reagent kit from 10X Genomics, Inc. 7068 Koll Center Parkway Suite 401 Pleasanton, California 94566. This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR 13.106-1(b)(2) and 13.501-(a)(1) using simplified acquisition procedures for commercial acquisitions. The North American Industry Classification System code is 334516 and the business size standard is 1,000 employees. Only one award will be made because of this solicitation. This will be awarded as a firm fixed price type contract. This will be awarded as a small business set aside. Delivery Date: 30 days from date of award. The acquisition of the proposed 10X Genomic Comium Controller system/reagent kit enables NCI researchers to perform next-generation sequencing, such as RNA-seq and TCR sequencing at the single-cell level. The single-cell sample preparation for next generation sequencing has been a challenging issue for NCI researchers, since it starts from a very small amount of material. This 10X Genomic system has shown that it can provide simple, fast and flexible solution for NCI researchers experiments and projects and produce cutting-edge and high-quality data for investigators research and publications. The following salient characteristics apply to the 10X Genomic Comium Controller System/ Reagent Kit: - Generation of single-cell RNA-seq samples from at least 4,000 cells per sample for the downstream sequencing and data analysis - Generation of single-cell TCR samples from at least 4,000 cells per sample for the downstream sequencing and data analysis This is not a solicitation for competitive quotations. However, if any interested party believes they can meet the above requirement, they may submit a statement of capabilities. All information furnished must be in writing and must contain enough detail to allow the NCI to determine if it can meet the above unique specifications described herein. An original and one copy of the capability statement must be received at the NCI, P-ARC on or before 11:00 AM EST on May 9, 2019. Electronic capability statements will be accepted. Questions shall be emailed to Lisa Hill, CCR Purchasing at lisa.hill@nih.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for determining whether to conduct a competitive procurement. To receive an award, contractors must have valid registration and certification in the System for Awards Management at sam.gov. No collect calls will be accepted. Please reference solicitation number NCI-5275214 on all correspondences. NCI-5275214 Department of Health and Human Services National Institutes of Health
4/24/19, 12:24 PM